{"id":335197,"date":"2026-11-02T16:07:01","date_gmt":"2026-11-02T10:37:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/procter-and-gamble-health-q2-results-fy27-pat-112-crore\/"},"modified":"2026-11-02T16:07:01","modified_gmt":"2026-11-02T10:37:01","slug":"procter-and-gamble-health-q2-results-fy27-pat-112-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/procter-and-gamble-health-q2-results-fy27-pat-112-crore\/","title":{"rendered":"Procter & Gamble Health Q2 Results FY27: Revenue Up 17.72% YoY to Rs 382.49 Cr, PAT Rs 111.51 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Procter & Gamble Health Q2 Results FY27 were declared on 2 November 2026 on a Standalone basis. The quarterly results show revenue of Rs 382.49 Cr, up 17.72% YoY from Rs 324.92 Cr. Net profit was Rs 111.51 Cr against Rs 88.54 Cr a year earlier, a YoY growth of 25.94%.<\/p>\n<\/div>\n

Procter & Gamble Health Ltd<\/a> (PGHL) Q2 Results FY27 announced on 2 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 382.49 Cr and PAT of Rs 111.51 Cr. These figures were declared on the Standalone basis, and the results date of 2 November 2026 anchors every comparison below. The article reads Procter & Gamble Health Q2 Results FY27 as filed.<\/p>\n

This Procter & Gamble Health Q2 Results results analysis covers the financial highlights, the business drivers disclosed in the data, the outlook framework and the risks worth tracking. It also sets out how standalone results for the quarter compare with the prior year, starting with the Financial Highlights table that follows.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n